SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Patel Chem Specialities Ltd (544460)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544460 NSE: Chemicals | Small Cap | Patel Chem Specialit Share Price

₹97 0.50 (0.52%)

As on 03-Jul'26 09:36

Patel Chem Specialities Ltd (544460)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544460 NSE: Chemicals | Small Cap | Patel Chem Specialit Share Price

₹97 0.50 (0.52%)

As on 03-Jul'26 09:36

Key Metrics
Valuation Multiples
Market Cap
₹240 Cr.
Current Price
₹97
52-Week Low / High
₹56 / 121
TTM EPS
₹5.1
TTM Sales
₹137 Cr.
Book Value per Share
₹40
P/E Ratio
19.12
In line with its 5-year historical median
Industry PE
52.9
Price to Book (P/B)
2.41
Higher than its 5-year historical median
Price to Sales (P/S)
1.75
Lower than its 5-year historical median
EV/EBITDA
13.46
In line with its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
38.47%
Outperforms industry median
Return on Capital Employed (ROCE)
35.23%
Outperforms industry median
Return on Assets (ROA)
18.82%
Operating Profit Margin
14.5%
Net Profit Margin
10.05%
Gross Profit Margin
14.1%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
27.6%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
30.85%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
37.99%
Asset Quality
Promoter Holding
68.64%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹75 Cr.
Equity
₹24.9 Cr.
Face Value
₹10
All Time Low / High
₹56.10 / 120.89

Patel Chem Specialities stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Patel Chem Specialities Ltd a good quality company?
Patel Chem Specialities Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Patel Chem Specialities Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Patel Chem Specialities Ltd vs industry peers?
Patel Chem Specialities Ltd revenue CAGR is 20.22%, compared to the industry median CAGR of 4.7%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Patel Chem Specialities Ltd?
Promoters hold 68.64% of the Patel Chem Specialities Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Patel Chem Specialities Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Patel Chem Specialities Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 24.7%26%38.7%35.2%-
Value Creation
Index
0.80.91.81.5-

Growth Parameters

Sales 60.569.482.4105137
Sales YoY Gr.-14.8%18.7%27.6%-
Adj EPS 1.31.64.45.85.1
YoY Gr.-20.6%178.5%32.5%-
BVPS (₹) 5.3711.519.840
Adj Net
Profit
2.22.77.510.413
Cash Flow from Ops. 2.126.11.9-
Debt/CF from Ops. 3.762.57.8-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA20.2%27.6%
Adj EPS NANA64.5%32.5%
BVPSNANA55.4%72.4%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
24.825.847.73816.9
Op. Profit
Mgn %
7.47.914.214.5NAN
Net Profit
Mgn %
3.73.99.19.99.2
Debt to
Equity
0.910.80.4-
Working Cap
Days
0951181190
Cash Conv.
Cycle
04054640

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales606982105
Operating Expenses + 56647190
Manufacturing Costs3477
Material Costs49555774
Employee Cost 2234
Other Costs 2335
Operating Profit 451215
Operating Profit Margin (%) 7.4%7.9%14.2%14.5%
Other Income + 0000
Exceptional Items 0000
Interest 1111
Depreciation 0111
Profit Before Tax 441014
Tax 1134
Profit After Tax 23811
PAT Margin (%) 3.8%4.2%9.3%10.1%
Adjusted EPS (₹)1.31.74.55.9
Dividend Payout Ratio (%)0%0%0%0%

Valuation of Patel Chem Specialit - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 9122035
Share Capital 11118
Reserves 8111918
Debt +8121515
Long Term Debt3578
Short Term Debt4697
Minority Interest0000
Trade Payables512810
Others Liabilities 2245
Total Liabilities 23374765

Fixed Assets

Net Fixed Assets +10141414
Gross Block13171818
Accumulated Depreciation3345
CWIP 00212
Investments 0000
Inventories271012
Trade Receivables10151521
Cash Equivalents 1011
Others Assets 1255
Total Assets 23374765

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 2262
PBT 441014
Adjustment 1111
Changes in Working Capital -2-2-4-10
Tax Paid -0-1-1-3
Cash Flow From Investing Activity + -4-3-6-7
Capex -5-4-3-11
Net Investments 0000
Others 21-33
Cash Flow From Financing Activity + 0105
Net Proceeds from Shares 0005
Net Proceeds from Borrowing 1211
Interest Paid -1-1-1-1
Dividend Paid 0000
Others 0-0-0-0
Net Cash Flow -1-000

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)25.3727.6848.7838.47
ROCE (%)24.7225.9738.7435.23
Asset Turnover Ratio2.582.291.961.87
PAT to CFO Conversion(x)10.670.750.18
Working Capital Days
Receivable Days57.8064.6067.3063.40
Inventory Days9.9022.103738.50
Payable Days35.2054.2063.1045.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Patel Chem Specialities Ltd FAQs

The current trading price of Patel Chem Specialit on 03-Jul-2026 09:36 is ₹97.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 02-Jul-2026 the market cap of Patel Chem Specialit stood at ₹240.0 Cr

The latest P/E ratio of Patel Chem Specialit as of 02-Jul-2026 is 19.12.

The latest P/B ratio of Patel Chem Specialit as of 02-Jul-2026 is 2.41.

The 52-week high of Patel Chem Specialit is ₹120.9 and the 52-week low is ₹56.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Patel Chem Specialit is ₹137 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Patel Chem Specialities Ltd is a below average quality company.

The key valuation ratios of Patel Chem Specialities Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Patel Chem Specialities Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Patel Chem Specialities Ltd

Patel Chem Specialities Limited was originally incorporated on June 25, 2008, as a private limited company as ‘Patel Chem Specialities Private Limited’ under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Pursuant to a special resolution passed by the Shareholders at their Extra ordinary General Meeting held on July 4 2024, the company was converted from a private limited company to public limited company and consequently, the name of the company was changed to ‘Patel Chem Specialities Limited’ and a fresh Certificate of Incorporation consequent to conversion was issued on August 29, 2024, by the Registrar of Companies, Central Processing Centre.

The company operates in the field of specialty chemicals, particularly focusing on the production of cellulose-based excipients. It manufactures a diverse range of products that are critical to various industries, including pharmaceuticals, food & beverages, cosmetics, and numerous industrial applications. These chemicals are fundamental in the formulation of essential products such as tablets, food additives, personal care items, and industrial formulations. Its products play vital roles as binders, disintegrants, thickeners, stabilizers, and gelling agents, each serving a specialized function across multiple sectors.

Since inception, the company manufactures Carboxymethyl Cellulose Sodium (Sodium CMC), Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose Calcium (CMC Calcium), Croscarmellose Sodium (CCS), Sodium Starch Glycollate (SSG), and Sodium Monochloro Acetate (SMCA). With a commitment to quality and innovation, it has successfully established a strong global presence, exporting its products to many countries, including the USA, Germany, UK, Japan, China, Australia, and many more. Its expertise in producing high-quality excipients has enabled it to carve out a niche in the cellulose-based chemicals market, driven by its adherence to international quality standards such as US-DMF, GMP, ISO 9001:2015 etc.

The company offers a diverse range of cellulose-based chemicals, each serving specialized functions across various industries. Sodium CMC, a versatile product, is used as a thickener, binder, and gelling agent in pharmaceuticals, food & beverages, cosmetics, and industrial applications such as oil drilling, under the brand ‘Rheollose’. Microcrystalline Cellulose (MCC) is valued in pharmaceuticals and food & beverages as a bulking agent, texturizer, and binder, with products branded as ‘Hindcel’. Sodium Starch Glycollate (SSG) serves as a disintegrant in tablets, available in corn (BlowTab C) and potato-based (BlowTab P) variants. Croscarmellose Sodium and Calcium CMC, powerful super disintegrants, are marketed as Disolwell and 'Swellcal’, respectively.

Business area of the company

The company is one of the leading manufacturing companies in chemical based on caustic soda flaks, maize, methanol and manufacturing CMC, SSG and other types of similar material mainly used pharma, food and other chemical industries.

Products of the company

  • Sodium Monochloro Acetate (SMCA)
  • Blowtab - Sodium Starch Glycolate (SSG)
  • Disolwell - Croscaremellose Sodium (CCS)
  • Swellcal - Carboxymethyl Cellulose Calcium (Calcium CMC)
  • Rheollose - Sodium Carboxymethyl Cellulose (Sodium CMC)
  • Hindcell - Microcrystalline Cellulose (MCC)

History and milestones

  • 2008: Incorporation of the Company.
  • 2021: Company acquired a land at Indrad, Mahesana, with an area of 9,409 square meters.
  • 2022: Company acquired a Talod Unit (Land and, Plant and Machinery), Himmatnagar, with an area of 6,767 square meters.
  • 2022: Crossed Rs 50 crore revenue.
  • 2023: Recognized as One Star Export House.
  • 2023: Received MSME ZED Bronze Certificate.
  • 2024: The company was converted from a private limited company into a public limited company.
  • 2025: Vatva Unit is registered as US-FDA approved facility.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: